SEARCH

SEARCH BY CITATION

References

  • 1
    Koopen NR, Müller M, Vonk RJ, Zimniak P, Kuipers F. Molecular mechanisms of cholestasis: causes and consequences of impaired bile formation. Biochim Biophys Acta 1998; 1408: 1-17.
  • 2
    Reichen J, Simon FR. Cholestasis. In: AriasMI, JakobyWB, PopperH, SchachterD, ShafritzDA, eds. The Liver: Biology and Pathobiology. 2nd ed. New York: Raven Press, 1988: 1105-1124.
  • 3
    Kramer HJ. Impaired renal function in obstructive jaundice: roles of the thromboxane and endothelin systems. Nephron 1997; 77: 1-12.
  • 4
    Wait RB, Kahng KU. Renal failure complicating obstructive jaundice. Am J Surg 1989; 157: 256-263.
  • 5
    Fleck Ch, Bräunlich H. Renal handling of drugs and amino acids after impairment of kidney or liver function-Influences of maturity and protective treatment. Pharmacol Ther 1995; 67: 53-57.
  • 6
    Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004; 84: 987-1049.
  • 7
    Burckhardt G, Wolff NA. Structure of renal organic anion and cation transporters. Am J Physiol 2000; 278: F853-F866.
  • 8
    Sweet DH, Bush KT, Nigam SK. The organic anion transporter family: from physiology to ontogeny and the clinic. Am J Physiol 2001; 281: F197-F205.
  • 9
    Cha SH, Sekine T, Fukushima J-I, Kanai Y, Kobayashi Y, Goya T, et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 2001; 59: 1277-1286.
  • 10
    Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997; 272: 18526-18529.
  • 11
    Smeets PH, van Aubel RA, Wouterse AC, van den Heuvel JJ, Russel FG. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter. J Am Soc Nephrol 2004; 15: 2828-2835.
  • 12
    Van Aubel R, Peters JG, Masereeuw R, Van Os CH, Russel FGM. Multidrug resistance protein Mrp2 mediates ATP-dependent transport of classical renal organic anion p-aminohippurate. Am J Physiol 2000; 279: F713-F717.
  • 13
    Tanaka Y, Kobayashi Y, Gabazza EC, Higuchi K, Kamisako T, Kuroda M, et al. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am J Physiol 2002; 282: G656-G662.
  • 14
    Brandoni A, Quaglia NB, Torres AM. Compensation increase in organic anion excretion in rats with acute biliary obstruction: role of the renal organic anion transporter 1. Pharmacology 2003; 68: 57-63.
  • 15
    Jackson E. Diureticos. In: HardmanJG, LimbirdLE, MolinoffPB, RuddonRW, Goodman GilmanA, eds. Las Bases Farmacológicas de la Terapéutica. 9th ed. Mexico: McGraw-Hill Interamericana, 1996: 735-766.
  • 16
    Okusa MD, Ellison DH. Physiology and pathophysiology of diuretics. In: SeldinDW, GiebischG, eds. The Kidney Physiology and Pathophysiology. Philadelphia: Lippincott Williams & Wilkins, 2000: 2877-2922.
  • 17
    Hasannejad H, Takeda M, Taki K, Shin HJ, Babu E, Jutabha P, et al. Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther 2004; 308: 1021-1029.
  • 18
    Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, et al. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999; 274: 13675-13680.
  • 19
    Uwai Y, Saito H, Hashimoto Y, Inui KI. Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter r OAT1. J Pharmacol Exp Ther 2000; 295: 261-265.
  • 20
    Cerrutti JA, Quaglia NB, Brandoni A, Torres AM. Effects of gender on the pharmacokinetics of drug secreted by the renal organic anions transport systems in the rat. Pharm Res 2002; 45: 107-112.
  • 21
    Cerrutti JA, Quaglia NB, Torres AM. Characterization of the mechanisms involved in the gender differences in p-aminohippurate renal elimination in rats. Can J Physiol Pharmacol 2001; 79: 805-813.
  • 22
    Quaglia NB, Hofer CG, Torres AM. Pharmacokinetics of organic anions in rats with arterial calcinosis. Clin Exp Pharmacol Physiol 2002; 29: 48-52.
  • 23
    Shumaker R. PKCALC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab Rev 1986; 17: 331-348.
  • 24
    Motulsky H. Using nonlinear regression to fit curves. In: MotulskyH, ed. Intuitive Biostatistics. New York: Oxford University Press, 1995: 227-283.
  • 25
    Bratton AC, Marshall EK Jr. Determination of p-aminohippurate. J Biol Chem 1939; 128: 537-542.
  • 26
    Brandoni A, Villar SR, Torres AM. Gender-related differences in the pharmacodynamics of furosemide in rats. Pharmacology 2004; 70: 107-112.
  • 27
    Quaglia NB, Brandoni A, Ferri A, Torres AM. Early manifestation of nephropathy in rats with arterial calcinosis. Renal Fail 2003; 25: 355-366.
  • 28
    Quaglia NB, Brandoni A, Villar SR, Torres AM. Haemodynamic and tubular renal dysfunction in rats with sustained arterial calcinosis. Clin Exp Pharmacol Physiol 2004; 31: 231-236.
  • 29
    Roe HH. A photometric method for determination of inulin in plasma and urine. J Biol Chem 1949; 178: 839-844.
  • 30
    Jensen RE, Berndt WO. Epinephrine and norephinephrine enhance p-aminohippurate transport into basolateral membrane vesicles. J Pharmacol Exp Ther 1988; 244: 543-549.
  • 31
    Cerrutti JA, Brandoni A, Quaglia NB, Torres AM. Sex differences in p-aminohippuric acid transport in rat kidney: role of membrane fluidity and expression of OAT1. Mol Cell Biochem 2002; 233: 175-179.
  • 32
    Schoner W, Von Ilberg C, Kramer R, Seubert W. On the mechanism of Na+ and K+ stimulation hydrolysis of adenosine triphosphate. Eur J Biochem 1967; 1: 334-343.
  • 33
    Widnell CB. Purification of rat liver 5′nucleotidase as a complex with sphingomyelin. Methods Enzymol 1974; 32: 368-374.
  • 34
    Torres AM, MacLaughlin M, Quaglia NB, Stremmel W. Role of BSP/bilirubin binding protein on p-aminohippurate transport in rat kidney. Mol Cell Biochem 2003; 248: 149-156.
  • 35
    Villar SR, Brandoni A, Anzai N, Endou H, Torres AM. Altered expression of rat renal cortical OAT1 and OAT3 in response to bilateral ureteral obstruction. Kidney Int 2005; 68: 2704-2713.
  • 36
    Sedmak JJ, Grossberg SE. A rapid, sensitive and versatile assay for protein using Coomassie Brilliant Blue G250. Anal Biochem 1977; 79: 544-552.
  • 37
    Villar SR, Brandoni A, Quaglia NB, Torres AM. Renal elimination of organic anions in rats with bilateral ureteral obstruction. Biochim Biophys Acta 2004; 1688: 204-209.
  • 38
    Torres AM, MacLaughlin M, Muller A, Brandoni A, Anzai N, Endou H. Altered renal elimination of organic anions in rats with chronic renal failure. Biochim Biophys Acta 2005; 1740: 29-37.
  • 39
    Tojo A, Sekine T, Nakajima N, Hosoyamada M, Kanai Y, Kimura K, et al. Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 1999; 10: 464-471.
  • 40
    Shah V, Cao S, Hendrickson H, Yao J, Katusic ZS. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am J Physiol 2001; 280: G1209-G1216.
  • 41
    Kojima R, Sekine T, Kawachi M, Cha SH, Suzuki Y, Endou H. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am Soc Nephrol 2002; 13: 848-857.
  • 42
    Wójcicki M, Drozdzik M, Sulikowski T, Wójcicki J, Gawronska-Szklarz B, Zielinski S, et al. Pharmacokinetics of intravenously administered digoxin and histopathological picture in rabbits with experimental bile duct obstruction. Eur J Pharm Sci 2000; 11: 215-222.
  • 43
    Sitprija V, Kashemsant U, Sriratanban A, Arthachinta S, Poshyachinda V. Renal function in obstructive jaundice in man:cholangiocarcinoma model. Kidney Int 1990; 38: 948-9555.
  • 44
    Miyazawa Y, Sato T, Kobayashi K, Akahori F, Suzuki T, Miyashita H. Influence of induced cholestasis on pharmacokinetics of digoxin and digitoxin in dogs. Am J Vet Res 1990; 51: 605-610.
  • 45
    Wilkinson GR. Clearance approaches in pharmacology. Pharmacol Rev 1987; 39: 1-47.
  • 46
    Ljubojevic M, Herak-Kramberger CM, Hagos Y, Bahn A, Endou H, Burckhardt G, et al. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol 2004; 287: F124-F138.
  • 47
    Plebani M, Panozzo MP, Basso D, De Paoli M, Biasin R, Infantolino D. Cytokines and the progression of liver damage in experimental bile duct ligation. Clin Exp Pharmacol Physiol 1999; 26: 358-363.